0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sexually Transmitted Diseases Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Othe-48
Home | Market Reports | Health| Reproductive Health
Global Sexually Transmitted Diseases Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sexually Transmitted Diseases Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Othe-48
Report
September 2022
103 Pages
QYResearch
Region: North America, Europe, Asia Pacific, South America, Middle East, Africa, Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sexually Transmitted Diseases Testing estimated at US$ 80070 million in the year 2022, is projected to reach a revised size of US$ 104270 million by 2028, growing at a CAGR of 4.5% during the forecast period 2022-2028.

The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sexually Transmitted Diseases Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sexually Transmitted Diseases Testing market. Further, it explains the major drivers and regional dynamics of the global Sexually Transmitted Diseases Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Sexually Transmitted Diseases Testing Segment by Type

Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other

Sexually Transmitted Diseases Testing Segment by Application

Clinics
Hospitals
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sexually Transmitted Diseases Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sexually Transmitted Diseases Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sexually Transmitted Diseases Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sexually Transmitted Diseases Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexually Transmitted Diseases Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Sexually Transmitted Diseases Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Sexually Transmitted Diseases Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Abbott and Qiagen, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Chlamydia Testing
1.2.3 Gonorrhea Testing
1.2.4 Syphilis Testing
1.2.5 HIV Testing
1.2.6 HSV Testing
1.2.7 HPV Testing
1.2.8 Chancroid Testing
1.2.9 Other
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Sexually Transmitted Diseases Testing Market Size (2017-2028)
2.2 Sexually Transmitted Diseases Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Sexually Transmitted Diseases Testing Market Size by Region (2017-2022)
2.4 Global Sexually Transmitted Diseases Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Sexually Transmitted Diseases Testing Countries Ranking by Market Size
3 Sexually Transmitted Diseases Testing Competitive by Company
3.1 Global Sexually Transmitted Diseases Testing Revenue by Players
3.1.1 Global Sexually Transmitted Diseases Testing Revenue by Players (2017-2022)
3.1.2 Global Sexually Transmitted Diseases Testing Market Share by Players (2017-2022)
3.2 Global Sexually Transmitted Diseases Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Sexually Transmitted Diseases Testing Revenue
3.4 Global Sexually Transmitted Diseases Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Testing Revenue in 2021
3.5 Global Sexually Transmitted Diseases Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Diseases Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Diseases Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Sexually Transmitted Diseases Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases Testing Historic Revenue by Type (2017-2022)
4.2 Global Sexually Transmitted Diseases Testing Forecasted Revenue by Type (2023-2028)
5 Global Sexually Transmitted Diseases Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Application (2017-2022)
5.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sexually Transmitted Diseases Testing Revenue by Company (2020-2022)
6.2 North America Sexually Transmitted Diseases Testing Revenue by Type (2017-2028)
6.3 North America Sexually Transmitted Diseases Testing Revenue by Application (2017-2028)
6.4 North America Sexually Transmitted Diseases Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases Testing Revenue by Company (2020-2022)
7.2 Europe Sexually Transmitted Diseases Testing Revenue by Type (2017-2028)
7.3 Europe Sexually Transmitted Diseases Testing Revenue by Application (2017-2028)
7.4 Europe Sexually Transmitted Diseases Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Sexually Transmitted Diseases Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Sexually Transmitted Diseases Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Sexually Transmitted Diseases Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Sexually Transmitted Diseases Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Sexually Transmitted Diseases Testing Revenue by Company (2020-2022)
9.2 Latin America Sexually Transmitted Diseases Testing Revenue by Type (2017-2028)
9.3 Latin America Sexually Transmitted Diseases Testing Revenue by Application (2017-2028)
9.4 Latin America Sexually Transmitted Diseases Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 BioMerieux
11.1.1 BioMerieux Company Details
11.1.2 BioMerieux Business Overview
11.1.3 BioMerieux Sexually Transmitted Diseases Testing Products and Services
11.1.4 BioMerieux Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.1.5 BioMerieux Sexually Transmitted Diseases Testing SWOT Analysis
11.1.6 BioMerieux Recent Developments
11.2 F. Hoffmann La Roche
11.2.1 F. Hoffmann La Roche Company Details
11.2.2 F. Hoffmann La Roche Business Overview
11.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Products and Services
11.2.4 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.2.5 F. Hoffmann La Roche Sexually Transmitted Diseases Testing SWOT Analysis
11.2.6 F. Hoffmann La Roche Recent Developments
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Sexually Transmitted Diseases Testing Products and Services
11.3.4 BD Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.3.5 BD Sexually Transmitted Diseases Testing SWOT Analysis
11.3.6 BD Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Sexually Transmitted Diseases Testing Products and Services
11.4.4 Abbott Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.4.5 Abbott Sexually Transmitted Diseases Testing SWOT Analysis
11.4.6 Abbott Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Products and Services
11.5.4 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.5.5 Bio-Rad Laboratories Sexually Transmitted Diseases Testing SWOT Analysis
11.5.6 Bio-Rad Laboratories Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Sexually Transmitted Diseases Testing Products and Services
11.6.4 Abbott Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.6.5 Abbott Sexually Transmitted Diseases Testing SWOT Analysis
11.6.6 Abbott Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Sexually Transmitted Diseases Testing Products and Services
11.7.4 Qiagen Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022)
11.7.5 Qiagen Sexually Transmitted Diseases Testing SWOT Analysis
11.7.6 Qiagen Recent Developments
12 Sexually Transmitted Diseases Testing Market Dynamics
12.1 Sexually Transmitted Diseases Testing Market Trends
12.2 Sexually Transmitted Diseases Testing Market Drivers
12.3 Sexually Transmitted Diseases Testing Market Challenges
12.4 Sexually Transmitted Diseases Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Chlamydia Testing
    Table 3. Key Players of Gonorrhea Testing
    Table 4. Key Players of Syphilis Testing
    Table 5. Key Players of HIV Testing
    Table 6. Key Players of HSV Testing
    Table 7. Key Players of HPV Testing
    Table 8. Key Players of Chancroid Testing
    Table 9. Key Players of Other
    Table 10. Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Sexually Transmitted Diseases Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 12. Global Sexually Transmitted Diseases Testing Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Sexually Transmitted Diseases Testing Revenue Market Share by Region (2017-2022)
    Table 14. Global Sexually Transmitted Diseases Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Sexually Transmitted Diseases Testing Market Share by Players (2017-2022)
    Table 16. Global Top Sexually Transmitted Diseases Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2021)
    Table 17. Ranking of Global Top Sexually Transmitted Diseases Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Sexually Transmitted Diseases Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Sexually Transmitted Diseases Testing Product Solution and Service
    Table 21. Date of Key Manufacturers Enter into Sexually Transmitted Diseases Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Sexually Transmitted Diseases Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Sexually Transmitted Diseases Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2022)
    Table 29. Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Sexually Transmitted Diseases Testing Revenue Market Share by Application (2023-2028)
    Table 31. North America Sexually Transmitted Diseases Testing Revenue by Company (2020-2022) & (US$ Million)
    Table 32. North America Sexually Transmitted Diseases Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 33. North America Sexually Transmitted Diseases Testing Revenue by Type (2023-2028) & (US$ Million)
    Table 34. North America Sexually Transmitted Diseases Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 35. North America Sexually Transmitted Diseases Testing Revenue by Application (2023-2028) & (US$ Million)
    Table 36. North America Sexually Transmitted Diseases Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 37. North America Sexually Transmitted Diseases Testing Revenue by Country (2023-2028) & (US$ Million)
    Table 38. Europe Sexually Transmitted Diseases Testing Revenue by Company (2020-2022) & (US$ Million)
    Table 39. Europe Sexually Transmitted Diseases Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 40. Europe Sexually Transmitted Diseases Testing Revenue by Type (2023-2028) & (US$ Million)
    Table 41. Europe Sexually Transmitted Diseases Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Europe Sexually Transmitted Diseases Testing Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Europe Sexually Transmitted Diseases Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 44. Europe Sexually Transmitted Diseases Testing Revenue by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Company (2020-2022) & (US$ Million)
    Table 46. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Sexually Transmitted Diseases Testing Revenue by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Sexually Transmitted Diseases Testing Revenue by Company (2020-2022) & (US$ Million)
    Table 53. Latin America Sexually Transmitted Diseases Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Sexually Transmitted Diseases Testing Revenue by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Sexually Transmitted Diseases Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Sexually Transmitted Diseases Testing Revenue by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Sexually Transmitted Diseases Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Sexually Transmitted Diseases Testing Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Company (2020-2022) & (US$ Million)
    Table 60. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Sexually Transmitted Diseases Testing Revenue by Country (2023-2028) & (US$ Million)
    Table 66. BioMerieux Company Details
    Table 67. BioMerieux Business Overview
    Table 68. BioMerieux Sexually Transmitted Diseases Testing Product and Services
    Table 69. BioMerieux Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 70. BioMerieux Sexually Transmitted Diseases Testing SWOT Analysis
    Table 71. BioMerieux Recent Developments
    Table 72. F. Hoffmann La Roche Company Details
    Table 73. F. Hoffmann La Roche Business Overview
    Table 74. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product and Services
    Table 75. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 76. F. Hoffmann La Roche Sexually Transmitted Diseases Testing SWOT Analysis
    Table 77. F. Hoffmann La Roche Recent Developments
    Table 78. BD Company Details
    Table 79. BD Business Overview
    Table 80. BD Sexually Transmitted Diseases Testing Product and Services
    Table 81. BD Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 82. BD Sexually Transmitted Diseases Testing SWOT Analysis
    Table 83. BD Recent Developments
    Table 84. Abbott Company Details
    Table 85. Abbott Business Overview
    Table 86. Abbott Sexually Transmitted Diseases Testing Product and Services
    Table 87. Abbott Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 88. Abbott Sexually Transmitted Diseases Testing SWOT Analysis
    Table 89. Abbott Recent Developments
    Table 90. Bio-Rad Laboratories Company Details
    Table 91. Bio-Rad Laboratories Business Overview
    Table 92. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product and Services
    Table 93. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 94. Bio-Rad Laboratories Sexually Transmitted Diseases Testing SWOT Analysis
    Table 95. Bio-Rad Laboratories Recent Developments
    Table 96. Abbott Company Details
    Table 97. Abbott Business Overview
    Table 98. Abbott Sexually Transmitted Diseases Testing Product and Services
    Table 99. Abbott Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 100. Abbott Sexually Transmitted Diseases Testing SWOT Analysis
    Table 101. Abbott Recent Developments
    Table 102. Qiagen Company Details
    Table 103. Qiagen Business Overview
    Table 104. Qiagen Sexually Transmitted Diseases Testing Product and Services
    Table 105. Qiagen Sexually Transmitted Diseases Testing Revenue in Sexually Transmitted Diseases Testing Business (2017-2022) & (US$ Million)
    Table 106. Qiagen Sexually Transmitted Diseases Testing SWOT Analysis
    Table 107. Qiagen Recent Developments
    Table 108. Sexually Transmitted Diseases Testing Market Trends
    Table 109. Sexually Transmitted Diseases Testing Market Drivers
    Table 110. Sexually Transmitted Diseases Testing Market Challenges
    Table 111. Sexually Transmitted Diseases Testing Market Restraints
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sexually Transmitted Diseases Testing Sales Market Share by Type: 2021 VS 2028
    Figure 2. Chlamydia Testing Features
    Figure 3. Gonorrhea Testing Features
    Figure 4. Syphilis Testing Features
    Figure 5. HIV Testing Features
    Figure 6. HSV Testing Features
    Figure 7. HPV Testing Features
    Figure 8. Chancroid Testing Features
    Figure 9. Other Features
    Figure 10. Global Sexually Transmitted Diseases Testing Sales Market Share by Application: 2021 VS 2028
    Figure 11. Clinics Case Studies
    Figure 12. Hospitals Case Studies
    Figure 13. Other Case Studies
    Figure 14. Sexually Transmitted Diseases Testing Report Years Considered
    Figure 15. Global Sexually Transmitted Diseases Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Sexually Transmitted Diseases Testing Market Size 2017-2028 (US$ Million)
    Figure 17. Global Sexually Transmitted Diseases Testing Market Size Market Share by Region: 2021 VS 2028
    Figure 18. Global Sexually Transmitted Diseases Testing Revenue Market Share by Region in 2017 VS 2022
    Figure 19. Global Top 10 Sexually Transmitted Diseases Testing Countries Ranking by Market Size (US$ Million) in 2021
    Figure 20. Global Sexually Transmitted Diseases Testing Market Share by Players in 2021
    Figure 21. Global Top Sexually Transmitted Diseases Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2021)
    Figure 22. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases Testing Revenue in 2021
    Figure 23. North America Sexually Transmitted Diseases Testing Revenue Market Share by Company in 2021
    Figure 24. North America Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2028)
    Figure 25. North America Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2028)
    Figure 26. North America Sexually Transmitted Diseases Testing Revenue Share by Country (2017-2028)
    Figure 27. U.S. Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 28. Canada Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 29. Europe Sexually Transmitted Diseases Testing Revenue Market Share by Company in 2021
    Figure 30. Europe Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2028)
    Figure 31. Europe Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2028)
    Figure 32. Europe Sexually Transmitted Diseases Testing Revenue Share by Country (2017-2028)
    Figure 33. Germany Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 34. France Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 35. U.K. Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 36. Italy Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 37. Russia Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Sexually Transmitted Diseases Testing Revenue Market Share by Company in 2021
    Figure 39. Asia Pacific Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2028)
    Figure 40. Asia Pacific Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2028)
    Figure 41. Asia Pacific Sexually Transmitted Diseases Testing Revenue Share by Region (2017-2028)
    Figure 42. China Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 43. Japan Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 44. South Korea Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 45. India Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 46. Australia Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 47. China Taiwan Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 48. Indonesia Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 49. Thailand Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 50. Malaysia Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 51. Latin America Sexually Transmitted Diseases Testing Revenue Market Share by Company in 2021
    Figure 52. Latin America Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2028)
    Figure 53. Latin America Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2028)
    Figure 54. Latin America Sexually Transmitted Diseases Testing Revenue Share by Country (2017-2028)
    Figure 55. Mexico Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 56. Brazil Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 57. Argentina Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 58. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Company in 2021
    Figure 59. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Type (2017-2028)
    Figure 60. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Application (2017-2028)
    Figure 61. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Share by Country (2017-2028)
    Figure 62. Turkey Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 63. Saudi Arabia Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 64. UAE Sexually Transmitted Diseases Testing Revenue (2017-2028) & (US$ Million)
    Figure 65. BioMerieux Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 66. F. Hoffmann La Roche Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 67. BD Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 68. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 70. Abbott Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 71. Qiagen Revenue Growth Rate in Sexually Transmitted Diseases Testing Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5600
This license allows only one user to access the PDF.

Electronic (PDF)
$8400
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11200
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension
SIMILAR REPORTS